Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
5	7	Search

2024	Targeting O-GlcNAcylation in cancer therapeutic resistance: The sugar Saga continues Cancer Letters Lulu Chen, Mengxue Hu, Luojun Chen, Yihan Peng, Cai Zhang, Xin Wang, Xiangpan Li, Yi Yao, Qibin Song, Jing Li, Huadong Pei
2022	Alpelisib-Induced Diabetes Mellitus: Case Report, Pharmacodynamics and Management Considerations Frontiers in Endocrinology Begoña Pla Peris, Alfonso Arranz Martin, Anabel Ballesteros García, Fernando Sebastián-Valles, Monica Marazuela Azpiroz
2021	The prognostic outcome of ‘type 2 diabetes mellitus and breast cancer’ association pivots on hypoxia-hyperglycemia axis Cancer Cell International Ilhaam Ayaz Durrani, Attya Bhatti, Peter John
2021	O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers Frontiers in Immunology David E. Spaner
2020	ROR2 knockdown suppresses breast cancer growth through PI3K/ATK signaling Aging Muhong Guo, Ge Ma, Xiaolan Zhang, Weiwei Tang, Junfeng Shi, Qian Wang, Ye Cheng, Bin Zhang, Jin Xu
	Additional cited-by details will be shown when available from Crossref